Found 0 matching trials
Treatment of Peripheral T-cell Lymphoma
PHASE4The purpose of this study is to evaluate the efficacy and safety of GDPT re...
Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma
N/AThe clinical incidence of intrahepatic cholangiocarcinoma (ICC) is high and...
Location
Multiple Locations
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
PHASE2Background:
* Surgical resection is the treatment of choice for patients w...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
PHASE2Cisplatin is a very important agent for the treatment of TCC as it has a si...
Location
University of Chicago
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
PHASE2A single-arm, interventional study combining Immunotherapy and propranolol ...
Location
Cross Cancer Institute
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
PHASE2This is a pre-surgical study involving subjects with local advanced bladder...
Location
Zhujiang Hospital
Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP
PHASE3This is a european randomised, phase III, multi-centric study comparing a d...
Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.
PHASE2To assess the antitumour activity (response rate) in patients with locally ...
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
PHASE1This is a prospective, single-arm, phase II clinical trial. The purpose of ...
Location
Sun Yat-sen University Cancer Center
CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study
PHASE2This is a randomised, open-label phase II study comparing GEM-P chemotherap...
Location
Royal Marsden NHS Foundation Trust - London and Surrey